(Q22251241)

PubMed

PubMed publication ID

17702630

Parkinsonism and Related Disorders

7 February 2023

language of work or name

English

0 references

publication date

September 2007

0 references

published in

0 references

volume

13

0 references

page(s)

S8-S12

0 references

cites work

The quality of life in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Factors impacting on quality of life in Parkinson's disease: results from an international survey.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Burden of parkinsonism: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Burden of illness in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

The health burdens of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Economic burden and quality of life impairment increase with severity of PD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Timely levodopa (LD) administration prolongs survival in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Cost of Parkinson's disease in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

The Burden of Parkinson's Disease on Society, Family, and the Individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

What contributes to quality of life in patients with Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

Can the impact of ageing on health care costs be avoided?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

The Impact of Parkinson??s Disease on Health Status, Health Expenditures, and Productivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PARKRELDIS.2007.06.003

7 January 2021